7020-55-5C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2HOOSGZJRQIVJSZ-UHFFFAOYSA-NClidinium is the ester resulting from formal condensation of benzilic acid and 3-hydroxy-1-methyl-1-azoniabicyclo[2.2.2]octane. It is used, generally as the bromide, for the symptomatic treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. It has a role as an anti-arrhythmia drug, a parasympatholytic and an antispasmodic drug. It is an organic cation, a carboxylic ester and a quaternary ammonium ion. It is functionally related to a 3-quinuclidinol and a benzilic acid.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
BO76JF850N
CLIDINIUM
Established Pharmacologic Class [EPC] - Anticholinergic
Physiologic Effects [PE] - Decreased Parasympathetic Acetylcholine Activity
Physiologic Effects [PE] - GI Motility Alteration
Physiologic Effects [PE] - Digestive/GI System Activity Alteration
DefinitionChEBI: The ester resulting from formal condensation of benzilic acid and 3-hydroxy-1-methyl-1-azoniabicyclo[2.2.2]octane. It is used, generally as the bromide, for the symptomatic treatment of peptic ulcer disease and also to help relieve abdominal or stomach spa ms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome.
Loading…
Loading…
No reaction records under the current filter.
Loading…
7020-55-5DTXSID6045379CHEMBL620CHEBI:3743